Principal

  • Polymedco Inc.

    Since 1980, Polymedco has served medical professionals in providing patients comprehensive healthcare services. We are the world leader in non-invasive fecal immunochemical testing technology and bladder cancer monitoring. Combined with an experienced team of field representatives and strong technical service personnel, Polymedco provides a high level of customer technical and reimbursement support.
    Polymedco specializes in customizing a FIT mailing program to keep patients and members up to date with important routine colorectal cancer screening.

    Know More
  • Era Biology Group

    Era Biology Group, started business operation in 1997, is one of the leaders and pioneers of invasive fungal disease diagnosis around the world. Now we have eight subsidaries: Beijing Gold Mountainriver Tech Development Co., Ltd., Genobio Pharmaceutical Co., Ltd., Era Biology (Shanghai) Co., Ltd., Era Biology (Guangzhou) Co., Ltd., Era Biology (Suzhou) Co., Ltd., Beihai Sinlon Biotech Co., Ltd., Era Biology Group, LLC., and Era Biology (Canada) Co., Ltd.. Era Biology has passed the authentications of CMD ISO 9001, ISO 13485, Korea GMP and North America MDSAP, and has most products certificated by CE, NMPA and FSC.

    In China, Era Biology, joint National Center for Clinical Laboratories etc, successfully drafted the industrial standard of “Fungus (1-3)-β-D-Glucan Test” in 2017. There are totally 2433 tertiary-level hospitals across the country, in which over 80% of these hospitals are users of our products. Globally, our products are exported to more than 30 countries and regions around the world. Our products are rapid, easy to use, quantitative, and accurate, which are of great value in early diagnostics for invasive fungal infection.
    Know More
  • Pictor Limited

    Pictor is a biotechnology company based in Auckland, New Zealand. The company develops, manufactures and markets immunodiagnostic products based on a multiplexed and miniaturized ELISA technology platform.

    Pictor was founded in 2005 by two entrepreneurial scientists, Dr Anand Kumble and Dr Sarita Kumble. The founders retired from Pictor in 2017 and life sciences serial entrepreneur Howard Moore was appointed CEO.

    Since 2017, the Pictor team has expanded. The company now has over 30 employees between New Zealand, USA and India. There are over 400 laboratories in India that are using Pictor’s multiplex PictArrays to screen for maternal infections, auto immune diseases and hepatitis.

    Know More
  • Apacor Limited

    Apacor strives to be unique in our approach to product creation, ensuring a close connection between every stage, whether design and development, or manufacture and marketing.

    We excel in developing quality solutions to suit our customer’s every requirement, and with 25 years of gold-standard pre-analytical development, we continue to push new ground-breaking ideas to a global market.

    As we look to the future, we now embark on our next exciting chapter, in the continued development of world-leading innovation in parasitology and pre-analytical diagnostics.

    Know More
  • Zybio Inc.

    Zybio Inc. (referred to as ‘Zybio’) is a national high-tech enterprise founded in 2008, one of the leading Chinese medical company dedicated in a comprehensive line of IVD reagents and equipment, including Chemistry, Hematology, POCT, Molecule, Immunoassay, Biomaterials.

    Since the beginning, Zybio has implemented high standard in all aspects in terms of research & development, production, marketing, sales and technical services, to satisfy the needs of our users.

    Based on the ideology of “plan together, create together, share together”, we have set up a network of operations throughout China and keep expanding globally.

    Know More
  • Q-lineBiotech Pvt. Ltd.

    Great brands and great people are our biggest assets. Sustainable, profitable growth can only be achieved in an organization which focuses on performance culture and where employees are engaged and empowered to be the best they can be.Future success depends on being lean, agile and competitive in a resource-challenged world. In three years, we have transformed our structure to enable us to move faster, innovate better and leverage our global scale.

    As we continue to build on the foundation laid down through the transformation programs over the last several years, Q-lineBiotech has developed an operational plan which hinges on 3 key elements – Accuracy , Affordability & Accessibility. These 3 elements combined together will ensure that Q-lineBiotech remains on an upward growth trajectory, improves profitability and most importantly impacts the lives of millions of Indians through the science of HealthCare.

    Know More

© Copyright 2022 Bio-State Inc.

Developed by Ncr IT Solutions